Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2021242136 - DRUG FOR A COMBINATION THERAPY FOR DISEASES CAUSED BY BETACORONAVIRUSES

Publication Number WO/2021/242136
Publication Date 02.12.2021
International Application No. PCT/RU2021/000041
International Filing Date 02.02.2021
IPC
A61K 31/435 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
A61K 31/44 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non-condensed pyridines; Hydrogenated derivatives thereof
A61P 31/12 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
CPC
A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
A61K 31/44
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
44Non condensed pyridines; Hydrogenated derivatives thereof
A61P 31/12
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
Applicants
  • ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НАУЧНО-ПРОИЗВОДСТВЕННАЯ КОМПАНИЯ "ФАРМАСОФТ" OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTIYU "NAUCHNO-PROIZVODSTVENNAYA KOMPANIYA "PHARMASOFT" [RU]/[RU]
Inventors
  • ЗАБОЗЛАЕВ, Александр Александрович ZABOZLAEV, Alexandr Alexandrovich
  • РОЖДЕСТВЕНСКИЙ, Александр Викторович ROZHDESTVENSKY, Alexandr Viktorovich
  • ПАЦИЯ, Мераби Георгиевич PATSIYA, Merabi Georgievich
Agents
  • КАЛИГАНОВА, Александра Игоревна KALIGANOVA, Alexandra Igorevna
Priority Data
202011765028.05.2020RU
Publication Language Russian (ru)
Filing Language Russian (RU)
Designated States
Title
(EN) DRUG FOR A COMBINATION THERAPY FOR DISEASES CAUSED BY BETACORONAVIRUSES
(FR) PRÉPARATION POUR TRAITEMENT COMPLEXE DE MALADIES INDUITES PAR BETA-CORONAVIRUS
(RU) ПРЕПАРАТ ДЛЯ КОМПЛЕКСНОЙ ТЕРАПИИ ЗАБОЛЕВАНИЙ, ВЫЗВАННЫХ БЕТА-КОРОНАВИРУСАМИ
Abstract
(EN) The invention relates to the field of medicine and pharmaceutics. Proposed is the use of 2-ethyl-6-methyl-3-hydroxypyridine succinate as an adjuvant drug in a combination therapy for diseases caused by betacoronaviruses, in particular diseases caused by the COVID-19 coronavirus.
(FR) L'invention se rapporte au domaine de la médecine et de la pharmacie. L'invention concerne l'utilisation de succinate de 2-éthyl-6-méthyl-3-hydroxypyridine en qualité de préparation adjuvante dans le traitement complexe de maladies induites par Beta-coronavirus, notamment de maladies induites par le coronavirus COVID-19.
(RU) Изобретение относится к области медицины и фармации. Предложено применение 2-этил-6-метил-3-гидроксипиридина сукцината в качестве адъювантного препарата в комплексной терапии заболеваний, вызванных бета-коронавирусами, в частности, заболеваний, вызванных коронавирусом COVID-19.
Latest bibliographic data on file with the International Bureau